ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670791 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670791; 2) Community: the network communities that were significantly associated with the response to NSC 670791; 3) Molecule: the relationships between components within communities and NSC 670791; 4) MDR: the compounds that were significantly associated with the NSC 670791.

NSC Compound Enrichment Correlation
NSC 628297 Null 0.0241085022307781 0.23043244
NSC 639976 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride 0.0241085022307781 0.60309112
NSC 640083 Null 0.0241085022307781 0.47724386
NSC 641389 Null 0.0241085022307781 0.36716185
NSC 643860 Null 0.0241085022307781 0.43777713
NSC 643864 Null 0.0241085022307781 0.49134715
NSC 646498 Null 0.0241085022307781 0.6271996
NSC 653823 Null 0.0241085022307781 0.29955374
NSC 659853 2-Methoxy-.beta.-estradiol 0.0241085022307781 0.48597974
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0247979034812109 0.60401085
Total:108  Current:63    [First] [Prev] [Next] [Last]